vTv Therapeutics (VTVT) Short term Debt (2014 - 2015)
vTv Therapeutics' (VTVT) quarterly Short term Debt came in at $880000.0 in Q4 2015, up 42.39% year-over-year from $618000.0 in Q4 2014, and down 59.8% quarter-over-quarter from $2.2 million in Q2 2015.
Powered by 
Analysis
vTv Therapeutics (VTVT) Short term Debt (2014 - 2015) Analysis & Trends
vTv Therapeutics has disclosed Short term Debt across 2 years of filings, most recently posting $880000.0 for Q4 2015.
- In Q4 2015, Short term Debt rose 42.39% year-over-year to $880000.0; the TTM figure through Dec 2015 stood at $880000.0 (up 42.39% YoY), while the FY2015 annual figure was $880000.0, up 42.39% from the prior year.
- Short term Debt came in at $880000.0 for Q4 2015 at vTv Therapeutics, down from $2.2 million in the prior quarter.
- In the past five years, Short term Debt ranged from a high of $2.2 million in Q2 2015 to a low of $618000.0 in Q4 2014.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | vTv Therapeutics | 413.85 Mn | 413.85 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2015 | 880,000.00 |
| Jun 30, 2015 | 2.19 Mn |
| Dec 31, 2014 | 618,000.00 |